UBRELVY 50 mg/1 (Ubrogepant TABLET) 50 mg/1

UBRELVY 50 mg tablets contain ubrogepant, a medication used for acute migraine treatment. This oral tablet is designed to provide relief from migraine headaches. Learn more about ubrogepant and its uses.

Strength

50 mg/1

Pack Size

1 PACKET in 1 BOX (0023-6498-01) / 1 TABLET in 1 PACKET

Manufacturer / TM Owner

Allergan, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

UBRELVY 50 mg tablets are primarily used for the acute treatment of migraine headaches with or without aura in adults. Ubrogepant is a calcitonin gene-related peptide (CGRP) antagonist, which works by blocking the activity of CGRP, a molecule involved in migraine attacks. This medication is not intended for preventive use but rather for the relief of migraine symptoms once they begin.

Side Effects

Common effects of Ubrevly 50 mg tablets may include nausea, somnolence, and dry mouth. Some users may also experience fatigue or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Precautions & Warnings

UBRELVY 50 mg tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions. Avoid driving or operating heavy machinery if you experience drowsiness. Store the medication in a cool, dry place away from direct sunlight and out of reach of children.

Avoid Interactions

UBRELVY 50 mg tablets may interact with other medications, including strong CYP3A4 inducers and inhibitors. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while using this medication, as it may increase the risk of side effects.

Frequently Asked Questions

UBRELVY 50 mg tablets are used for the acute treatment of migraine headaches in adults.

UBRELVY 50 mg tablets are taken orally with or without food. Follow the dosage instructions provided by your healthcare professional.

Common side effects may include nausea, somnolence, dry mouth, fatigue, and dizziness.

UBRELVY may interact with other medications, so it is important to consult your healthcare provider before combining it with other drugs.

UBRELVY is intended for the acute treatment of migraines and not for long-term use. Consult your healthcare provider for personalized advice.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.